Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Titel:
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Auteur:
Arabi, Yaseen M. Gordon, Anthony C. Derde, Lennie P. G. Nichol, Alistair D. Murthy, Srinivas Beidh, Farah Al Annane, Djillali Swaidan, Lolowa Al Beane, Abi Beasley, Richard Berry, Lindsay R. Bhimani, Zahra Bonten, Marc J. M. Bradbury, Charlotte A. Brunkhorst, Frank M. Buxton, Meredith Buzgau, Adrian Cheng, Allen De Jong, Menno Detry, Michelle A. Duffy, Eamon J. Estcourt, Lise J. Fitzgerald, Mark Fowler, Rob Girard, Timothy D. Goligher, Ewan C. Goossens, Herman Haniffa, Rashan Higgins, Alisa M. Hills, Thomas E. Horvat, Christopher M. Huang, David T. King, Andrew J. Lamontagne, Francois Lawler, Patrick R. Lewis, Roger Linstrum, Kelsey Litton, Edward Lorenzi, Elizabeth Malakouti, Salim McAuley, Daniel F. McGlothlin, Anna Mcguinness, Shay McVerry, Bryan J. Montgomery, Stephanie K. Morpeth, Susan C. Mouncey, Paul R. Orr, Katrina Parke, Rachael Parker, Jane C. Patanwala, Asad E. Rowan, Kathryn M. Santos, Marlene S. Saunders, Christina T. Seymour, Christopher W. Shankar-Hari, Manu Tong, Steven Y. C. Turgeon, Alexis F. Turner, Anne M. Van de Veerdonk, Frank Leo Zarychanski, Ryan Green, Cameron Berry, Scott Marshall, John C. McArthur, Colin Angus, Derek C. Webb, Steven A. ,